1,1-dichloroethene increases expression ISO RGD:1314229 6480464 vinylidene chloride results in increased expression of RACGAP1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:1314229 6480464 1, 2-Dimethylhydrazine results in increased expression of RACGAP1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of RACGAP1 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:1314229 6480464 Ethinyl Estradiol affects the expression of RACGAP1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1314229 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RACGAP1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1314229 6480464 Ethinyl Estradiol results in increased expression of RACGAP1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1314228 6480464 Estradiol results in increased expression of RACGAP1 mRNA CTD PMID:16474171 more ... 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1314229 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1314229 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1314229 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RACGAP1 mRNA, AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of RACGAP1 mRNA] CTD PMID:15034205 , PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of RACGAP1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314229 6480464 Tetrachlorodibenzodioxin results in decreased expression of RACGAP1 mRNA CTD PMID:15034205 2,3-dimethoxynaphthalene-1,4-dione increases expression ISO RGD:1314228 6480464 2 more ... CTD PMID:17547211 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of RACGAP1 mRNA CTD PMID:17109745 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1314228 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RACGAP1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:1314229 6480464 Methylcholanthrene results in increased expression of RACGAP1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1314228 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RACGAP1 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:1314229 6480464 Fenretinide results in increased expression of RACGAP1 mRNA CTD PMID:28973697 5-azacytidine increases expression ISO RGD:1314228 6480464 Azacitidine results in increased expression of RACGAP1 mRNA CTD PMID:20823114 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of RACGAP1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of RACGAP1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1314228 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RACGAP1 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RACGAP1 mRNA CTD PMID:28959563 afimoxifene decreases expression ISO RGD:1314228 6480464 afimoxifene results in decreased expression of RACGAP1 mRNA CTD PMID:16514628 aflatoxin B1 affects expression ISO RGD:1314228 6480464 Aflatoxin B1 affects the expression of RACGAP1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of RACGAP1 mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of RACGAP1 mRNA CTD PMID:17109745 all-trans-retinoic acid decreases expression ISO RGD:1314228 6480464 Tretinoin results in decreased expression of RACGAP1 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1314228 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of RACGAP1 mRNA CTD PMID:32699268 AM-251 decreases expression ISO RGD:1314228 6480464 AM 251 results in decreased expression of RACGAP1 mRNA CTD PMID:16500647 aristolochic acid decreases expression ISO RGD:1314228 6480464 aristolochic acid I results in decreased expression of RACGAP1 protein CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:1314229 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of RACGAP1 mRNA CTD PMID:23650126 arsenite(3-) decreases expression ISO RGD:1314229 6480464 arsenite results in decreased expression of RACGAP1 mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO RGD:1314228 6480464 arsenite inhibits the reaction [G3BP1 protein binds to RACGAP1 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:1314228 6480464 Arsenic Trioxide results in increased expression of RACGAP1 mRNA CTD PMID:17547211 azathioprine decreases expression ISO RGD:1314228 6480464 Azathioprine results in decreased expression of RACGAP1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1314228 6480464 Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation ISO RGD:1314228 6480464 Benzo(a)pyrene affects the methylation of RACGAP1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1314229 6480464 Benzo(a)pyrene results in increased expression of RACGAP1 mRNA CTD PMID:20713471 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:1314229 6480464 Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA CTD PMID:15034205 benzo[a]pyrene multiple interactions ISO RGD:1314229 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of RACGAP1 mRNA], Benzo(a)pyrene promotes the reaction [AHR protein binds to RACGAP1 promoter] CTD PMID:15034205 , PMID:19654925 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1314228 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1314229 6480464 benzo(b)fluoranthene results in increased expression of RACGAP1 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of RACGAP1 mRNA CTD PMID:17109745 bicalutamide decreases expression ISO RGD:1314228 6480464 bicalutamide results in decreased expression of RACGAP1 mRNA CTD PMID:15638997 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1314228 6480464 Mustard Gas results in decreased expression of RACGAP1 mRNA CTD PMID:25102026 bisphenol A increases expression ISO RGD:1314228 6480464 bisphenol A results in increased expression of RACGAP1 mRNA CTD PMID:16474171 bisphenol A decreases expression ISO RGD:1314228 6480464 bisphenol A results in decreased expression of RACGAP1 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of RACGAP1 mRNA CTD PMID:25181051 more ... cadmium atom decreases expression ISO RGD:1314228 6480464 Cadmium results in decreased expression of RACGAP1 mRNA CTD PMID:21120746 , PMID:24376830 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of RACGAP1 mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1314228 6480464 Calcitriol results in decreased expression of RACGAP1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1314228 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RACGAP1 mRNA CTD PMID:21592394 carbon nanotube affects expression ISO RGD:1314229 6480464 Nanotubes, Carbon affects the expression of RACGAP1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1314229 6480464 Nanotubes, Carbon analog results in increased expression of RACGAP1 mRNA CTD PMID:25554681 cisplatin multiple interactions ISO RGD:1314228 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA] CTD PMID:21858171 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of RACGAP1 mRNA CTD PMID:22023808 copper atom multiple interactions ISO RGD:1314228 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RACGAP1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of RACGAP1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:1314228 6480464 [NSC 689534 binds to Copper] which results in decreased expression of RACGAP1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of RACGAP1 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO RGD:1314228 6480464 Copper Sulfate results in decreased expression of RACGAP1 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:1314228 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 coumestrol increases expression ISO RGD:1314228 6480464 Coumestrol results in increased expression of RACGAP1 mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO RGD:1314228 6480464 cupric oxide results in decreased expression of RACGAP1 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of RACGAP1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:1314228 6480464 Cyclosporine results in decreased expression of RACGAP1 mRNA CTD PMID:20106945 more ... dexamethasone multiple interactions ISO RGD:1314228 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RACGAP1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1314228 6480464 Arsenic Trioxide results in increased expression of RACGAP1 mRNA CTD PMID:17547211 dibenz[a,h]anthracene increases expression ISO RGD:1314229 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of RACGAP1 mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:1314229 6480464 Dichloroacetic Acid results in increased expression of RACGAP1 mRNA CTD PMID:28962523 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of RACGAP1 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of RACGAP1 mRNA CTD PMID:33729688 doxorubicin affects response to substance ISO RGD:1314228 6480464 RACGAP1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:1314228 6480464 Doxorubicin results in decreased expression of RACGAP1 mRNA CTD PMID:29803840 , PMID:30031762 Enterolactone increases expression ISO RGD:1314228 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in increased expression of RACGAP1 mRNA CTD PMID:19167446 Enterolactone multiple interactions ISO RGD:1314228 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of RACGAP1 mRNA CTD PMID:19167446 folic acid decreases expression ISO RGD:1314229 6480464 Folic Acid results in decreased expression of RACGAP1 mRNA CTD PMID:25629700 fulvestrant decreases expression ISO RGD:1314228 6480464 fulvestrant results in decreased expression of RACGAP1 mRNA CTD PMID:16514628 furan increases expression EXP 6480464 furan results in increased expression of RACGAP1 mRNA CTD PMID:25539665 gallic acid decreases expression ISO RGD:1314228 6480464 Gallic Acid results in decreased expression of RACGAP1 mRNA CTD PMID:34408198 genistein increases expression ISO RGD:1314228 6480464 Genistein results in increased expression of RACGAP1 mRNA CTD PMID:16474171 geraniol decreases expression ISO RGD:1314228 6480464 geraniol results in decreased expression of RACGAP1 mRNA CTD PMID:27683099 hexadecanoic acid decreases phosphorylation ISO RGD:1314228 6480464 Palmitic Acid results in decreased phosphorylation of RACGAP1 protein CTD PMID:28073184 indometacin multiple interactions ISO RGD:1314228 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RACGAP1 mRNA CTD PMID:28628672 isoflavones decreases expression ISO RGD:1314228 6480464 Isoflavones results in decreased expression of RACGAP1 mRNA CTD PMID:17374662 ivermectin decreases expression ISO RGD:1314228 6480464 Ivermectin results in decreased expression of RACGAP1 protein CTD PMID:32959892 leflunomide decreases expression ISO RGD:1314228 6480464 leflunomide results in decreased expression of RACGAP1 mRNA CTD PMID:28988120 lithium atom increases expression EXP 6480464 Lithium results in increased expression of RACGAP1 mRNA CTD PMID:21711903 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of RACGAP1 mRNA CTD PMID:21711903 lucanthone decreases expression ISO RGD:1314228 6480464 Lucanthone results in decreased expression of RACGAP1 mRNA CTD PMID:21148553 mercury atom increases expression ISO RGD:1314228 6480464 Mercury results in increased expression of RACGAP1 mRNA CTD PMID:17547211 mercury(0) increases expression ISO RGD:1314228 6480464 Mercury results in increased expression of RACGAP1 mRNA CTD PMID:17547211 methylphenidate decreases expression ISO RGD:1314229 6480464 Methylphenidate results in decreased expression of RACGAP1 mRNA CTD PMID:22470460 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:1314229 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA CTD PMID:19840844 N-nitrosodiethylamine multiple interactions ISO RGD:1314229 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RACGAP1 mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of RACGAP1 mRNA CTD PMID:19041683 N-Nitrosopyrrolidine decreases expression ISO RGD:1314228 6480464 N-Nitrosopyrrolidine results in decreased expression of RACGAP1 mRNA CTD PMID:32234424 nickel dichloride increases expression ISO RGD:1314228 6480464 nickel chloride results in increased expression of RACGAP1 mRNA CTD PMID:17547211 okadaic acid multiple interactions ISO RGD:1314229 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in increased expression of RACGAP1 mRNA CTD PMID:19840844 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RACGAP1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of RACGAP1 mRNA CTD PMID:25729387 ozone increases expression ISO RGD:1314229 6480464 Ozone results in increased expression of RACGAP1 mRNA CTD PMID:19555225 , PMID:25658374 ozone multiple interactions ISO RGD:1314228 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of RACGAP1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1314229 6480464 [NOTCH3 gene mutant form affects the susceptibility to Ozone] which affects the expression of RACGAP1 mRNA CTD PMID:25658374 palbociclib decreases expression ISO RGD:1314228 6480464 palbociclib results in decreased expression of RACGAP1 mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:1314228 6480464 Acetaminophen results in increased expression of RACGAP1 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1314229 6480464 [2 more ... CTD PMID:25510870 phenobarbital multiple interactions ISO RGD:1314229 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of RACGAP1 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RACGAP1 mRNA] CTD PMID:19482888 , PMID:24535843 phenobarbital increases expression ISO RGD:1314229 6480464 Phenobarbital results in increased expression of RACGAP1 mRNA CTD PMID:19482888 , PMID:23091169 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of RACGAP1 mRNA CTD PMID:29877212 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of RACGAP1 mRNA CTD PMID:22484513 pirinixic acid increases expression ISO RGD:1314229 6480464 pirinixic acid results in increased expression of RACGAP1 mRNA CTD PMID:17950772 , PMID:18301758 pirinixic acid multiple interactions ISO RGD:1314229 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of RACGAP1 mRNA] CTD PMID:17950772 piroxicam multiple interactions ISO RGD:1314228 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of RACGAP1 mRNA] CTD PMID:21858171 piroxicam increases expression ISO RGD:1314228 6480464 Piroxicam results in increased expression of RACGAP1 mRNA CTD PMID:21858171 progesterone decreases expression ISO RGD:1314228 6480464 Progesterone results in decreased expression of RACGAP1 mRNA CTD PMID:21795739 raloxifene decreases expression ISO RGD:1314228 6480464 Raloxifene Hydrochloride results in decreased expression of RACGAP1 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO RGD:1314228 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of RACGAP1 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of RACGAP1 mRNA CTD PMID:19167446 , PMID:23557933 resveratrol increases expression ISO RGD:1314228 6480464 resveratrol results in increased expression of RACGAP1 mRNA CTD PMID:19167446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of RACGAP1 mRNA CTD PMID:19013527 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of RACGAP1 mRNA CTD PMID:28374803 silicon dioxide increases expression ISO RGD:1314229 6480464 Silicon Dioxide results in increased expression of RACGAP1 mRNA CTD PMID:29341224 simvastatin decreases expression ISO RGD:1314228 6480464 Simvastatin results in decreased expression of RACGAP1 mRNA CTD PMID:17428261 sodium arsenite increases expression ISO RGD:1314228 6480464 sodium arsenite results in increased expression of RACGAP1 mRNA CTD PMID:29301061 Soman increases expression EXP 6480464 Soman results in increased expression of RACGAP1 mRNA CTD PMID:19281266 sunitinib decreases expression ISO RGD:1314228 6480464 Sunitinib results in decreased expression of RACGAP1 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1314229 6480464 Tamoxifen affects the expression of RACGAP1 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1314228 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of RACGAP1 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1314228 6480464 Testosterone results in decreased expression of RACGAP1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1314229 6480464 Carbon Tetrachloride results in increased expression of RACGAP1 mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane affects expression ISO RGD:1314229 6480464 Carbon Tetrachloride affects the expression of RACGAP1 mRNA CTD PMID:17484886 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RACGAP1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide affects expression ISO RGD:1314229 6480464 titanium dioxide affects the expression of RACGAP1 mRNA CTD PMID:17656681 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of RACGAP1 mRNA CTD PMID:30012374 titanium dioxide increases expression ISO RGD:1314229 6480464 titanium dioxide results in increased expression of RACGAP1 mRNA CTD PMID:23557971 , PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of RACGAP1 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of RACGAP1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:1314229 6480464 Trichloroethylene results in increased expression of RACGAP1 mRNA CTD PMID:25549359 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of RACGAP1 mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1314229 6480464 trimellitic anhydride results in increased expression of RACGAP1 mRNA CTD PMID:19042947 urethane increases expression ISO RGD:1314228 6480464 Urethane results in increased expression of RACGAP1 mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:1314228 6480464 Valproic Acid affects the expression of RACGAP1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1314228 6480464 Valproic Acid results in increased expression of RACGAP1 mRNA CTD PMID:29154799 vincaleukoblastine affects response to substance ISO RGD:1314228 6480464 RACGAP1 protein affects the susceptibility to Vinblastine CTD PMID:16217747 zaragozic acid A decreases expression ISO RGD:1314229 6480464 squalestatin 1 results in decreased expression of RACGAP1 mRNA CTD PMID:27225895 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of RACGAP1 mRNA CTD PMID:27225895
